
CURX P/E Ratio
P/E Ratio as of Sep 22, 2025: -66.88
Average-371.80
Median-487.18
Minimum-583.44
Maximum-66.88
-66.88
The P/E ratio for CURX is -66.88 as of Sep 22, 2025. This represents a increase of 67.62% compared to its 12-month average P/E ratio of -39.9. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Curanex Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Curanex Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Curanex Pharmaceuticals Inc to industry peers.
Curanex Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Curanex Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Curanex Pharmaceuticals Inc to industry peers.
CURX P/E Ratio Insights
See Curanex Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CURX
Order type
Buy in
Order amount
Est. shares
0 shares
CURX P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Sep 5, 2025 | $7.23 | -478.81 |
CURX End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -66.88 | — |
FAQs About Curanex Pharmaceuticals Inc (CURX) P/E ratio
The latest P/E ratio of CURX is -66.88, as of Sep 22, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Curanex Pharmaceuticals Inc’s last 12-month average P/E ratio is -39.9, compared to its current P/E ratio of -66.88. This reflects a increase of 67.62%.
Curanex Pharmaceuticals Inc’s current P/E ratio of -66.88 is higher than its last 12-month average P/E of -39.9. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Curanex Pharmaceuticals Inc’s average P/E ratio over the last 3 years is -13.3. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Curanex Pharmaceuticals Inc’s average P/E ratio over the last 5 years is -7.98. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.